Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Semaglutide Reduced Risks of Major Kidney Outcomes Irrespective of CKD Severity in the FLOW Trial

PaperCitations, authors & open-access status

Semaglutide Reduced Risks of Major Kidney Outcomes Irrespective of CKD Severity in the FLOW Trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 0 citations, 2026 year and closed oa status.

0
Citations
2026
Year
closed
OA Status

Related on ScholarIQ

V Perkovic
Author
Diabetes Treatment and Management
Topic
Diabetes Treatment and Management
Topic
Chronic Kidney Disease and Diabetes
Topic
Heart Failure Treatment and Management
Topic
470M+ articles · free account